Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Current methods can't fully recreate skin and its features, and more research is needed for clinical use.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Current therapies cannot fully regenerate adult skin without scars; more research is needed for scar-free healing.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Curly/coily hair products are more expensive than straight hair products.

Current hair restoration methods are improving and include medications, injections, light therapy, and advanced extraction techniques.

Researchers made a mouse model with curly hair and hair loss by editing a gene.

Current treatments for common male hair loss have limited effectiveness and can cause side effects.

A KRT71 mutation in Hereford cattle in Uruguay causes thin, curly hair and scaly skin.

Current methods can't accurately predict which long-form answers people prefer; evaluations should consider different answer qualities separately.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Two siblings have a rare genetic condition causing curly, coarse hair.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

No current system perfectly classifies male-pattern hair loss, indicating a need for a new system for better diagnosis and treatment.

The current state and future directions of the field that studies the connection between the mind and skin are discussed.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

The document says current treatments for alopecia areata do not cure or prevent it, and it's hard to judge their effectiveness due to spontaneous remission and lack of studies.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Tiny lipid particles carrying 17-α-estradiol gather in hair follicles, which may help target alopecia treatment.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.